CONFIRMING STATEMENT



This Statement confirms that the undersigned has authorized and

designated the Chief Executive Officer, the Chief Financial Officer

or the Chief Operating Officer of Galectin Therapeutics Inc (the

"Company") to execute and file on the undersigned's behalf all Forms 3

4 and 5 (including any amendments thereto) that the undersigned may be

required to file with the U.S. Securities and Exchange Commission as a

result of the undersigned's ownership of or transactions in securities

of the Company. The authority of the Chief Executive Officer, the Chief

Financial Officer or the Chief Operating Officer of the Company under

this Statement shall continue until the undersigned is no longer

required to file Forms 3 4 and 5 with regard to the undersigned's

ownership of or transactions in the securities of the Company unless

earlier revoked in writing The undersigned acknowledges that the

Chief Executive Officer, the Chief Financial Officer or the Chief

Operating Officer of the Company is not assuming any of the

undersigned's responsibilities to comply with Section 16 of the

Securities Exchange Act of 1934.







Dated as of September 23 2014  /s/ Gilbert S. Omenn

 Signature



 Gilbert S. Omenn

 Print Name